Clinical trials: Synergy Between Plasmid Inhibitors and Combined Antibiotics
Synergy Between Plasmid Inhibitors and Combined Antibiotics
Synergistic Effect of Plasmid Inhibitors and Antimicrobial Drugs Against Clinical MDR-hvKP
1. Screening for MDR-hvKP causing VAP in patients admitted to chest ICU in Assiut University Hospital. 2. In vitro evaluation of the synergistic activity of combined meropenem/levofloxacin with and without kasugamycin against…
- Trial name
- NCT05932355
- Volunteers
- 50 people
- Sponsor
- Assiut University